# Phase 1 Study of the Effects of Combining Topical FDA-approved Drugs on Age-related Pathways on the Skin of Healthy Volunteers

> **NCT03072485** · PHASE1 · COMPLETED · sponsor: **Anne Chang** · enrollment: 10 (actual)

## Conditions studied

- Aging

## Interventions

- **DRUG:** Sirolimus
- **DRUG:** Metformin
- **DRUG:** Diclofenac

## Key facts

- **NCT ID:** NCT03072485
- **Lead sponsor:** Anne Chang
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-01
- **Primary completion:** 2019-02-22
- **Final completion:** 2019-02-22
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03072485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03072485, "Phase 1 Study of the Effects of Combining Topical FDA-approved Drugs on Age-related Pathways on the Skin of Healthy Volunteers". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03072485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*